Delfidiagnostics
Senior Director, Assay Development
Palo Alto, CA · Director
Sponsorship not specified$275k-$310kDetected 69 days ago
Product StrategyFirewallNGS
About the role
- This role requires 4 days in the Palo Alto office.
Responsibilities
- We explore thoughtfully, experiment smartly, and deliver impact with conviction.
- Through teamwork, we build collective intelligence.
- As Senior Director of Assay Development, you will own all development activities across DELFI's NGS-based cancer screening portfolio - driving the transition of innovative assays into verified, validated, and manufacturable IVD products.
- DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer.
Compensation
- $275k-$310k
Benefits
- Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges.
- In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
- We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Company info
- We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
- We are a home for high-performing people.
- FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics' first laboratory-developed screening test and can be part of routine blood work.
Equal opportunity
- We are an equal opportunity employer and value diversity at our company.
- equal opportunity employer and value diversity at our company.
Apply directly at Delfidiagnostics →Create a free account for alerts like thisView Delfidiagnostics immigration profile
This listing is sourced directly from Delfidiagnostics's careers page and normalized into a canonical job model.